Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?

Bibliographic Details
Title: Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
Authors: Lisa Bauer, Debby van Riel
Source: mBio, Vol 14, Iss 1 (2023)
Publisher Information: American Society for Microbiology, 2023.
Publication Year: 2023
Collection: LCC:Microbiology
Subject Terms: neuropathogenesis, neuroinvasion, neurotropism, neurovirulence, CNS, astrocytes, Microbiology, QR1-502
More Details: ABSTRACT Neurological complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are a huge societal problem. Although the neuropathogenicity of SARS-CoV-2 is not yet fully understood, there is evidence that SARS-CoV-2 can invade and infect cells of the central nervous system. Kong et al. (https://doi.org/10.1128/mbio.02308-22) shows that the mechanism of virus entry into astrocytes in brain organoids and primary astrocytes differs from entry into respiratory epithelial cells. However, how SARS-CoV-2 enters susceptible CNS cells and whether there are differences among SARS-CoV-2 variants is still unclear. In vivo and in vitro models are useful to study these important questions and may reveal important differences among SARS-CoV-2 variants in their neuroinvasive, neurotropic, and neurovirulent potential. In this commentary we address how this study contributes to the understanding of the neuropathology of SARS-CoV-2 and its variants.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2150-7511
Relation: https://doaj.org/toc/2150-7511
DOI: 10.1128/mbio.02920-22
Access URL: https://doaj.org/article/8ae2e3e3feb1415ba71b4df088e3873d
Accession Number: edsdoj.8ae2e3e3feb1415ba71b4df088e3873d
Database: Directory of Open Access Journals
More Details
ISSN:21507511
DOI:10.1128/mbio.02920-22
Published in:mBio
Language:English